Our Role
Elliogen is not an exploitant.
We operate as an independent, conflict-free advisor, bridging pharmaceutical companies with licensed exploitants in France. We help define the most appropriate market-entry model, identify the right partners, and avoid costly regulatory, operational, and commercial pitfalls.
Our independence allows us to provide objective guidance tailored to each company’s strategy, stage of development, and long-term objectives.
Our Approach
We are committed to delivering high-quality, reliable support with a strong focus on clarity, execution, and long-term value creation.
Our work is characterised by dependability, responsiveness, and a pragmatic approach to problem-solving in complex regulatory and commercial environments.
Our Expertise
Our team combines academic excellence, consulting experience, and hands-on industry expertise across the pharmaceutical value chain.
This breadth allows us to act not simply as consultants, but as strategic advisors embedded in our clients’ decision-making processes.
Marketing
We support pharmaceutical companies in launching or repositioning products in France and Europe.
Our work spans market intelligence, competitive positioning, branding, and patient-focused messaging — all grounded in robust market insight.
We leverage a strong network across manufacturers, distributors, wholesalers, French exploitants, and patient advocacy groups to support effective market access and visibility.
Business Development
We advise on partnership strategy and execution, from partner identification to early commercial discussions.
Our focus is on structuring sustainable collaborations aligned with both regulatory requirements and long-term commercial objectives.
Early Access Programs (EAP)
We provide end-to-end strategic support for Early Access Programs, ensuring regulatory alignment, operational readiness, and a clear pathway to future commercialisation — with patient access at the core.
Trusted by
The partner company you introduced us to has substantial experience in the Exploitant role, working with several European manufacturers. They were already planning to expand into our specific field of activity, and now, we have an exciting opportunity to build this market together. Their expertise in regulatory compliance, reimbursement processes, and hospital tenders, combined with their status as an active Exploitant company, complements our deep knowledge and experience in our specialized area.
Amit Patel, CEO Pharmanovia
I must add that this connection would not have been possible without your assistance. Neither Google nor even ChatGPT could have led us to this partner — you made it happen, and for that, we are sincerely grateful.
Thank you once again for your professionalism, dedication, and invaluable support.
Dr. László, Commercial Director, Medi-Radiopharmaceutical
I had the pleasure of working with Elliogen for two years. They were tasked with commercial responsibility for a number of European markets. This involved accountability for sales performance along with formulating strategies across the product portfolio. They displayed great enthusiasm and tenacity in addition to finding innovative solutions to difficult problems.
